表 1.
SCG2表达量与结直肠癌患者临床特征的相关性
Association between SCG2 expression and clinicopathological features of patients with colorectal cancer
Characteristics | SCG2 expression | ||||
Total (n=96) | Low (n=48) | High (n=48) | χ2 | P | |
*P<0.05 (Chi-square test). | |||||
Gender | |||||
Male | 52 | 23 | 29 | 1.51 | 0.2191 |
Female | 44 | 25 | 19 | ||
Age (year) | |||||
<65 | 44 | 24 | 20 | 0.6713 | 0.4126 |
≥65 | 52 | 24 | 28 | ||
T stage | |||||
T1-T2 | 3 | 2 | 1 | 0.2813 | 0.5959 |
T3-T4 | 90 | 46 | 44 | ||
N stage | |||||
N0 | 55 | 36 | 19 | 10.07 | 0.0015* |
N1+N2+N3 | 40 | 13 | 27 | ||
M stage | |||||
M0 | 93 | 47 | 46 | 0.3441 | 0.5575 |
M1 | 3 | 1 | 2 | ||
Clinical stage | |||||
Ⅰ/Ⅱ | 54 | 37 | 15 | 26.08 | < 0.0001* |
Ⅲ/Ⅳ | 40 | 7 | 33 |